Mr. Doyle has served as our Executive Chairman since 2016, as Chairman of the Board since 2009 and as a member of our Board of Directors since 2004. Mr. Doyle has been the managing director of WFD Ventures LLC, a private venture capital firm he co-founded, since 2002. Prior to 2002, Mr. Doyle was a member of Johnson & Johnson’s Medical Devices and Diagnostics Group Operating Committee and was Vice President, Licensing and Acquisitions. While at Johnson & Johnson, Mr. Doyle was also chairman of the Medical Devices Research and Development Council, and Worldwide president of Biosense-Webster, Inc. and a member of the board of directors of Cordis Corporation and Johnson & Johnson Development Corporation, Johnson & Johnson’s venture capital subsidiary. Earlier in his career, Mr. Doyle was a management consultant in the healthcare group of McKinsey & Company. Mr. Doyle is also a member of the Governing Board of the Pershing Square Sohn Cancer Research Alliance. From 2014 to 2016 he was a member of the investment team at Pershing Square Capital Management L.P., a private investment firm.
Education: S.B. in materials science and engineering, Massachusetts Institute of Technology; M.B.A., Harvard Business School.
Other Public Company Directorships: Director of Elanco Animal Health, Inc. since 2020 and director of Minerva Neurosciences, Inc. since 2017. Formerly a director of OptiNose, Inc. from 2004 to 2020 and Zoetis, Inc. from 2015 to 2016.
What is William F. Doyle's net worth?
The estimated net worth of William F. Doyle is at least $6.64 million as of August 2nd, 2022. Mr. Doyle owns 551,176 shares of NovoCure stock worth more than $6,641,671 as of April 19th. This net worth estimate does not reflect any other investments that Mr. Doyle may own. Additionally, Mr. Doyle receives a salary of $1,520,000.00 as Chairman at NovoCure. Learn More about William F. Doyle's net worth.
How old is William F. Doyle?
Mr. Doyle is currently 62 years old. There are 7 older executives and no younger executives at NovoCure. The oldest executive at NovoCure is Prof. Yoram Palti M.D., Ph.D., Founder & CTO, who is 86 years old. Learn More on William F. Doyle's age.
What is William F. Doyle's salary?
As the Chairman of NovoCure Limited, Mr. Doyle earns $1,520,000.00 per year. The highest earning executive at NovoCure is Mr. Asaf Danziger, CEO & Director, who commands a salary of $1,700,000.00 per year. Learn More on William F. Doyle's salary.
How do I contact William F. Doyle?
Has William F. Doyle been buying or selling shares of NovoCure?
William F. Doyle has not been actively trading shares of NovoCure over the course of the past ninety days. Most recently, William F. Doyle sold 837 shares of the business's stock in a transaction on Tuesday, August 2nd. The shares were sold at an average price of $69.66, for a transaction totalling $58,305.42. Following the completion of the sale, the chairman now directly owns 551,176 shares of the company's stock, valued at $38,394,920.16. Learn More on William F. Doyle's trading history.
Who are NovoCure's active insiders?
NovoCure's insider roster includes Michael Ambrogi (COO), Ely Benaim (Insider), Ashley Cordova (CFO), Asaf Danziger (CEO), William Doyle (Chairman), Wilhelmus Groenhuysen (COO), Jeryl Hilleman (Director), Frank Leonard (Insider), Gabriel Leung (Director), Todd Longsworth (General Counsel), Martin Madden (Director), Pritesh Shah (Insider), and Uri Weinberg (Insider). Learn More on NovoCure's active insiders.
Are insiders buying or selling shares of NovoCure?
During the last twelve months, insiders at the medical equipment provider sold shares 9 times. They sold a total of 9,753 shares worth more than $163,632.37. The most recent insider tranaction occured on March, 4th when EVP Frank X Leonard sold 840 shares worth more than $13,448.40. Insiders at NovoCure own 5.7% of the company.
Learn More about insider trades at NovoCure. Information on this page was last updated on 3/4/2024.
